BOSTON--(BUSINESS WIRE)--Acurian Inc., a leading full-service provider of global patient enrollment and retention solutions, and Synexus, the leading global network of dedicated research sites, have ...

Strong clinical results, including significant reductions in liver fat, improvements in glycemic control, and fibrosis regression without worsening of NASH, support the efficacy and potential of EFX.

The prevalence of NASH in global populations continues to expand in conjunction with the ongoing obesity and diabetes epidemic. Over the next decade, the disease is projected to become the leading ...

NEW YORK--(BUSINESS WIRE)--Harvey Nash, an IT recruitment, IT offshoring and executive search firm, has been named to the Allegis Global Solutions (AGS) 2019 Strategic Partner Program. Harvey Nash is ...